Growth Stocks To Consider - November 18th

Prologis logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Prologis (PLD), a global logistics real-estate company, was one of the growth stocks flagged for high recent dollar trading volume. Its shares slipped to $125.24, near the reported 1-year low of $121.40.
  • Ascendis Pharma (ASND), which markets SKYTROFA and is developing rare-disease and oncology therapies, was also highlighted. Shares rose to $271.37, close to the 12-month high of $282.15.
  • Teledyne Technologies (TDY), a provider of industrial technologies including digital imaging and sensors, rounded out the list. Its shares gained $4.55 to $623.91.
  • Five stocks we like better than Prologis.

Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies that investors expect to grow revenue or earnings faster than the overall market. These companies often reinvest profits to expand rather than pay large dividends, and their prices can be more volatile because they depend heavily on expectations of future growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Shares of PLD stock traded down $0.32 during midday trading on Wednesday, reaching $125.24. 1,367,303 shares of the company traded hands, compared to its average volume of 3,774,817. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.81 and a quick ratio of 0.81. The firm has a market cap of $119.04 billion, a PE ratio of 27.66, a price-to-earnings-growth ratio of 1.45 and a beta of 1.27. Prologis has a 1-year low of $121.40 and a 1-year high of $153.35. The firm's 50 day simple moving average is $130.20 and its two-hundred day simple moving average is $137.73.

Read Our Latest Research Report on PLD

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Shares of NASDAQ ASND traded up $0.18 on Wednesday, hitting $271.37. The company's stock had a trading volume of 199,897 shares, compared to its average volume of 701,624. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.89 and a quick ratio of 2.29. The stock has a 50 day moving average of $242.71 and a 200-day moving average of $240.31. The company has a market capitalization of $16.93 billion, a price-to-earnings ratio of 17.75 and a beta of 0.40. Ascendis Pharma A/S has a 12-month low of $188.08 and a 12-month high of $282.15.

Read Our Latest Research Report on ASND

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

TDY stock traded up $4.55 during trading on Wednesday, hitting $623.91. The stock had a trading volume of 78,548 shares, compared to its average volume of 345,582. Teledyne Technologies has a 1-year low of $483.02 and a 1-year high of $697.67. The stock has a market cap of $28.72 billion, a price-to-earnings ratio of 28.56, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89. The company's 50 day moving average price is $622.67 and its two-hundred day moving average price is $635.50. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.51 and a current ratio of 2.31.

Read Our Latest Research Report on TDY

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Prologis Right Now?

Before you consider Prologis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.

While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines